Infinity Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 14 shareholders own 3.05% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
1.31%	Adelene Perkins	1,191,738	€3.1k	42.9%	no data
1.07%	Lawrence Bloch	966,932	€2.5k	0%	no data
0.24%	Anthony Evnin	215,403	€557.4	0%	no data
0.2%	XTX Holdings Limited, Asset Management Arm	181,068	€468.6	0%	no data
0.11%	Bg Fund Management Luxembourg S.A.	100,606	€260.4	0%	no data
0.041%	Stephane Peluso	37,052	€95.9	0%	no data
0.034%	Brian Schwartz	30,919	€80.0	0%	no data
0.017%	Norman Selby	15,000	€38.8	0%	no data
0.012%	Samuel Agresta	10,593	€27.4	0%	no data
0.0097%	David Beier	8,775	€22.7	0%	no data
0.0055%	SunAmerica Asset Management, LLC	4,968	€12.8	0%	no data
0.0039%	Highlander Capital Management LLC	3,500	€9.1	0%	no data
0.0011%	SagePoint Financial Advisors, Inc., Securities Investments	1,000	€2.6	0%	no data
0.00011%	Steward Partners Investment Advisory, LLC	100	€0.3	0%	no data